$358.7 M

MSTX Mkt cap, 31-Aug-2018
Mast Therapeutics Net income (Q3, 2018)-12.6 M
Mast Therapeutics EBIT (Q3, 2018)-12.8 M
Mast Therapeutics Cash, 30-Sep-201824.9 M

Mast Therapeutics Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

128.0k

Revenue growth, %

(100%)

R&D expense

12.9m19.4m28.3m20.8m18.5m

General and administrative expense

11.0m9.3m11.1m

Operating expense total

12.9m19.4m39.4m36.6m30.0m

Depreciation and amortization

146.0k99.0k363.0k

EBIT

(21.5m)(29.3m)(39.4m)(36.5m)(30.0m)

EBIT margin, %

(28481%)

Interest expense

603.0k2.1m1.2m

Interest income

60.3k69.0k130.0k122.0k

Pre tax profit

(21.5m)(28.7m)(39.8m)(38.5m)(33.4m)

Income tax expense

2.4m3.6m

Net Income

(21.5m)(28.7m)(39.8m)(36.1m)(29.8m)

Mast Therapeutics Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

25.7m35.8m23.1m8.5m22.1m

Inventories

1.1m1.1m1.3m903.0k

Current Assets

45.5m58.4m42.3m12.2m97.9m

PP&E

105.7k188.0k226.0k99.0k925.0k

Goodwill

3.0m3.0m3.0m3.0m27.1m

Total Assets

55.2m70.5m54.2m17.9m159.6m

Accounts Payable

963.9k1.4m2.6m626.0k2.8m

Current Liabilities

4.8m8.4m23.2m4.9m6.0m

Long-term debt

297.0k

Total Debt

297.0k

Total Liabilities

7.4m30.3m8.2m40.3m

Additional Paid-in Capital

254.2m293.7m298.7m320.6m186.5m

Retained Earnings

(235.1m)(275.0m)(311.1m)(68.2m)

Total Equity

47.8m58.7m23.9m9.8m119.3m

Debt to Equity Ratio

0 x

Debt to Assets Ratio

0 x

Financial Leverage

1.2 x1.2 x2.3 x1.8 x1.3 x

Mast Therapeutics Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(21.5m)(28.7m)(39.8m)(36.1m)(29.8m)

Depreciation and Amortization

39.5k85.0k146.0k99.0k363.0k

Accounts Payable

2.5m1.2m159.0k

Cash From Operating Activities

(17.8m)(24.6m)(32.9m)(37.3m)(28.2m)

Purchases of PP&E

(46.8k)(147.0k)(165.0k)(8.0k)(495.0k)

Cash From Investing Activities

(4.8m)481.0k3.4m15.2m(69.1m)

Long-term Borrowings

(3.6m)

Cash From Financing Activities

25.7m34.3m16.8m7.6m106.1m

Mast Therapeutics Ratios

USDY, 2018

Financial Leverage

1.3 x
Report incorrect company information

Mast Therapeutics Employee Rating

00 votes
Culture & Values
N/A
Work/Life Balance
N/A
Senior Management
N/A
Salary & Benefits
N/A
Career Opportunities
N/A
Source